Devices for Inhaled Medications Market
Devices for Inhaled Medications Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Devices for Inhaled Medications Market Size and Growth
The global Devices for Inhaled Medications market is projected to reach a value of $39.4 billion by 2025, with a CAGR of 6.8% during the forecast period. The market is driven by the increasing prevalence of respiratory diseases and the growing demand for effective and convenient drug delivery systems for inhaled medications. Key players in the market include GlaxoSmithKline, Novartis, and AstraZeneca.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Consort Medical
◍ Inhalexper
◍ Cambridge Consultants
◍ Hovione
◍ Catalent, Inc
◍ VertMarkets, Inc
◍ Qualicaps
◍ 3M
◍ Aerovance
◍ AstraZeneca
◍ Boehringer Ingelheim
◍ Chiesi
◍ Cipla
◍ Civitas/Alkermes
◍ GlaxoSmithKline
◍ Hovione
◍ Mannkind
◍ Mantecorp
The Devices for Inhaled Medications Market is competitive, with companies like Consort Medical, Cambridge Consultants, Catalent, and Novartis offering innovative inhalation devices. These companies help grow the market by developing user-friendly and efficient devices for delivering inhaled medications.
- Consort Medical: $957.7 million
- Boehringer Ingelheim: $22.7 billion
- GlaxoSmithKline: $40.1 billion
Request Sample Report
Market Segmentation
By Application
Clinic
Hospital
Household
By Product
◍ Dry Powder Inhalers ◍ Metered-Dose Inhalers ◍ Nebulizers ◍ Soft Mist Inhaler
Request Sample Report
◍
◍
◍
$ 1898.41 Million
Request Sample Report
Market Growth
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients